Search
Search Results
##search.searchResults.foundPlural##
-
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1677PDF: 606HTML: 238 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2575PDF: 960HTML: 324 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1119PDF: 882HTML: 255 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3390PDF: 1384HTML: 2696 -
-
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
868PDF: 490HTML: 1310 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4440PDF: 3650HTML: 226 -
-
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1512PDF: 899HTML: 324 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3154PDF: 929HTML: 2087 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4824PDF: 1580HTML: 2254Untitled: 229Untitled: 249Untitled: 255Untitled: 229Untitled: 237 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3485PDF: 1320HTML: 1939Fig.1: 223Fig. 2: 221 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4421PDF: 1785HTML: 1112 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1842PDF: 1188HTML: 258 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
975PDF: 576HTML: 2202Cover Letter: 202 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2155PDF: 1200HTML: 278 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3716PDF: 913HTML: 6729 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
748PDF: 474HTML: 6274 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3569PDF: 908HTML: 1670figure 1: 174Untitled: 201 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2468PDF: 1613HTML: 664 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3387PDF: 1348HTML: 6208 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2159PDF: 840HTML: 1648Figure 1: 563 -
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN
2026PDF: 876HTML: 1162Cover: 192 -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3280PDF: 932HTML: 767text and figure: 238 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1149PDF: 974HTML: 345







